Table 1 Patients’ characteristics according to absence or presence of AAA
|  | All patients (n = 566) | No AAA (n = 526, 92.9%) | AAA ≥ 30 mm (n = 40, 7.1%) | p-value |
|---|---|---|---|---|
Age (median, IQR) | 78.0 [72.0–82.0] | 77.0 [72.0–82.0] | 78.5 [74.8–83.0] | 0.41 |
 Heart rate (bpm) | 74.9 ± 14.6 | 75.0 ± 14.8 | 73.4 ± 12.0 | 0.51 |
 RR sys (mmHg) | 140.3 ± 19.3 | 140.5 ± 19.2 | 138.0 ± 20.7 | 0.43 |
 RR dia (mmHg) | 80.4 ± 11.1 | 80.5 ± 11.2 | 79.1 ± 10.8 | 0.44 |
 Total cholesterol (mg/dl) | 132.1 ± 43.9 | 131.9 ± 43.8 | 137.2 ± 49.7 | 0.72 |
 LDL (mg/dl) | 91.7 ± 32.7 | 91.8 ± 32.7 | 88.0 ± 32.9 | 0.73 |
Comorbidities, n (%) | ||||
 Hyperlipidemia | 370 (65.4) | 339 (64.4) | 31 (77.5) | 0.11 |
 Hypertension | 470 (83.0) | 433 (82.3) | 37 (92.5) | 0.10 |
 History of smoking | 327 (57.8) | 294 (55.9) | 33 (82.5) | 0.01 |
 Diabetes mellitus | 251 (44.3) | 240 (45.6) | 11 (27.5) | 0.03 |
 CAD | 393 (69.4) | 360 (68.4) | 33 (82.5) | 0.01 |
 Coronary 3-vessel-disease | 194 (34.3) | 168 (31.9) | 26 (65.0) | <  0.0001 |
 Chronic kidney disease (GFR < 60 ml/min) | 340 (60.1) | 311 (59.1) | 29 (72.5) | 0.14 |
Main diagnosis, n (%) | ||||
 ACS | 246 (43.5) | 224 (42.6) | 22 (55.0) | 0.13 |
 Heart failure | 182 (32.2) | 174 (33.1) | 8 (20.0) | 0.09 |
 Exacerbation of COPD/ Pneumonia | 68 (12.0) | 63 (12.0) | 5 (12.5) | 0.92 |
 Others | 31 (5.5) | 28 (5.3) | 3 (7.5) | 0.56 |
Main symptoms, leading to hospital admission, n (%) | ||||
 Angina pectoris | 166 (29.3) | 155 (29.5) | 11 (27.5) | 0.79 |
 Dyspnea | 208 (36.7) | 189 (35.9) | 19 (47.5) | 0.14 |
 Palpitations/ Syncope | 104 (18.4) | 99 (18.8) | 5 (12.5) | 0.32 |
 Others | 35 (6.2) | 34 (6.5) | 1 (2.5) | 0.32 |
Concomitant medication, n (%) | ||||
 Betablocker | 331 (58.5) | 308 (58.6) | 23 (57.5) | 0.90 |
 Calcium channel blocker | 100 (17.7) | 96 (18.3) | 4 (10.0) | 0.19 |
 ACE inhibitor/ ARB | 444 (78.4) | 411 (78.1) | 33 (82.5) | 0.52 |
 Statin | 375 (66.3) | 339 (64.5) | 36 (90.0) | 0.001 |
 Antiplatelet therapy | 312 (55.1) | 284 (54.0) | 28 (70.0) | <  0.05 |
 VKA/ DOAC | 190 (33.6) | 177 (33.7) | 13 (32.5) | 0.88 |